Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178676 | SCV000230801 | uncertain significance | not provided | 2018-03-15 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000178676 | SCV000927493 | uncertain significance | not provided | 2017-12-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000806672 | SCV000946685 | likely benign | Autosomal recessive polycystic kidney disease | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000806672 | SCV001320060 | uncertain significance | Autosomal recessive polycystic kidney disease | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001358740 | SCV001554588 | uncertain significance | not specified | 2024-01-26 | criteria provided, single submitter | clinical testing | Variant summary: PKHD1 c.7675G>C (p.Val2559Leu) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0012 in 1613106 control chromosomes in the gnomAD database, including 2 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in PKHD1 causing Polycystic Kidney And Hepatic Disease (0.0012 vs 0.0071), allowing no conclusion about variant significance. c.7675G>C has been reported in the literature in individuals affected with Polycystic Kidney And Hepatic Disease without strong evidence for causality (e.g. Sharp_2005, Tavira_2015). These report(s) do not provide unequivocal conclusions about association of the variant with Polycystic Kidney And Hepatic Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 15805161, 25701400). ClinVar contains an entry for this variant (Variation ID: 197602). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Ambry Genetics | RCV003352795 | SCV004054814 | uncertain significance | Inborn genetic diseases | 2023-08-02 | criteria provided, single submitter | clinical testing | The c.7675G>C (p.V2559L) alteration is located in exon 48 (coding exon 47) of the PKHD1 gene. This alteration results from a G to C substitution at nucleotide position 7675, causing the valine (V) at amino acid position 2559 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003977466 | SCV004795668 | likely benign | PKHD1-related condition | 2024-01-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV000806672 | SCV001455249 | uncertain significance | Autosomal recessive polycystic kidney disease | 2018-03-26 | no assertion criteria provided | clinical testing | |
Laboratory of Gastroenterology and Hepatology, |
RCV001844817 | SCV001877014 | likely benign | Autosomal dominant polycystic liver disease | 2021-09-01 | no assertion criteria provided | research | |
Genome Diagnostics Laboratory, |
RCV000178676 | SCV001930057 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000178676 | SCV001964007 | likely benign | not provided | no assertion criteria provided | clinical testing |